The Global Fund play a significant role in global markets for health products for these three diseases as a key financier and support countries get the most value for their investment. To ensure that the Global Fund’s purchasing power is best used to impact the three diseases, our Board has approved a Market Shaping Strategy.
The sourcing and management of health products which ranges from antiretrovirals (ARVs), anti-malarials, TB medicines, insecticide-treated nets to laboratory supplies is a critical component of the response to AIDS, TB and malaria.
One key tool for maximizing the purchasing power is the Pooled Procurement Mechanism, through which we are able to negotiate the best prices and delivery conditions with manufacturers on behalf of our Principal Recipients.
Through this mechanism, a strategy for each category of health product is developed using a standardized, rigorous and analytical approach. All procurement is guided by the relevant Global Fund quality assurance and procurement policies. Information on all procurement carried out by Global Fund-supported programs is made available through our online database, the Price & Quality Reporting tool.
Between 2012 and 2015, the Global Fund has seen measurable results in sourcing products through global tenders, including:
Another tool is our new online procurement platform, wambo.org. This innovative e-marketplace will allow implementers to search and compare pricing and availability across all suppliers, and will let suppliers reach a broader market.
Our focus is on improving value for money to maximize our impact on the three diseases, as outlined in the Board’s approved Market Shaping Strategy.
With such a significant role to play in the global market for health products, it is critical that our strategies for sourcing is based on market intelligence reflecting demand and supply; is in compliance with our procurement requirements and quality assurance policies and based on a standardized and rigorous approach.
Ensuring access to lifesaving health products is a cornerstone of the progress we have made and will continue to make in the fight against AIDS, TB and malaria.
Based on the Board’s Market Shaping Strategy, we have developed an approach for core health products, including:
Other health products such as: medicines for opportunistic infections, condoms and lab supplies will also eventually be included.
These strategies were developed and implemented following a four-step process: